Unclaimed Scholar Profile
Are you Elizea Horne? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-3421-2966-1671 orcid.org/0000-0002-9236-3110
Elizea Horne
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand (ZA), specializing in Agricultural, Environmental & Life Sciences. [Discipline: Agricultural, Environmental & Life Sciences] [Scholar Type: Policy & Economics Specialist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#HIV/AIDS Research and Interventions#SARS-CoV-2 and COVID-19 Research#HIV/AIDS drug development and treatment#COVID-19 Clinical Research Studies
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 7,328 | 3,517 |
| h-index | 10 | 8 |
| i10-index | 10 | 7 |
Annual Citation Growth
Verified Citations / Year0
2020352
2021+40%492
2022+29%633
2023+33%844
2024-8%774
2025-45%422
2026Scholarship Distribution & Proportions17 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (6,009) • 18% Global Research Impact (1,319)
17 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (17)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
Published in The Lancet HIV•2021
DOI: 10.1016/s2352-3018(21)00157-0 Verified Peer-Reviewed
Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa
Published in Clinical Infectious Diseases•2020
DOI: 10.1093/cid/ciaa1872 Verified Peer-Reviewed
Showing 1 – 5 of 17 publications
1 / 4